Health Care: Drugs

Cardiome Pharma Corp (CRME: NASDAQ)

$8.93 -0.02 | -0.22%
09/30/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 4.51M 789.00K 1.50M 66.06M
Cost of Sales 936.00K 0.00 0.00 0.00
Gross Operating Profit 3.58M 789.00K 1.50M 66.06M
Selling, General, and Administrative Expenses 16.45M 9.61M 11.55M 12.88M
Research & Development 476.00K 6.02M 15.22M 15.34M
Operating Income before D & A (EBITDA) -13.35M -14.84M -25.27M 37.85M
Depreciation & Amortization 649.00K 1.23M 1.10M 1.15M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 20.16M 12.06M 756.00K 803.00K
Special Income / Charges 0.00 0.00 -95.00K -25.00K
Total Income Before Interest Expenses (EBIT) 4.96M -14.05M -25.70M 37.47M
Interest Expense 87.00K 4.27M 2.22M 1.98M
Pre-Tax Income 4.88M -18.32M -27.92M 35.50M
Income Taxes 102.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 4.77M -18.32M -27.92M 35.50M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.77M -18.32M -27.92M 35.50M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.77M -18.32M -27.92M 35.50M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.98M -8.28M -27.82M 35.52M
Preferred Dividends
Net Income Available To Common 4.77M -18.32M -27.92M 35.50M
Basic EPS from Continuing Ops. 0.37 -1.49 -2.28 2.92
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.37 -1.49 -2.28 2.92
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.01 -0.02 -0.02
Basic EPS, Total 0.37 -1.50 -2.30 2.90
Basic Normalized Net Income/Share 0.47 -0.68 -2.28 2.92
EPS fr Continuing Ops. 0.37 -1.49 -2.28 2.89
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.37 -1.49 -2.28 2.89
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.01 -0.02 0.01
EPS, Total 0.37 -1.50 -2.30 2.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.46 -0.68 -2.28 2.90
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CRME

Latest CRME Headlines from TheStreet

More Financial News for CRME

Press Releases for CRME

See All Press Releases

Partner Headlines for CRME

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter